Antimicrobial peptides kill bacteria through multiple mechanisms beyond just poking holes in their membranes — they can also enter cells and shut down essential internal processes.
3+ killing mechanismsBeyond three models of membrane pore formation, antimicrobial peptides can inhibit cell wall synthesis, DNA replication, protein synthesis, and more
What the researchers found
Antimicrobial peptides kill bacteria through more mechanisms than just punching holes in membranes. While three classic pore-forming models exist — 'barrel-stave,' 'carpet,' and 'toroidal-pore' — growing evidence shows that many peptides can also cross into bacterial cells and inhibit internal processes including cell wall synthesis, nucleic acid synthesis, protein synthesis, enzymatic activity, and membrane septum formation during cell division.
Why it matters
Understanding how antimicrobial peptides actually kill bacteria is essential for developing them as antibiotics. If peptides work through multiple mechanisms simultaneously — membrane disruption and internal target inhibition — bacteria would have a much harder time developing resistance, making these peptides particularly valuable in the age of antibiotic resistance.
How the study worked
This is a comprehensive review published in Nature Reviews Microbiology examining the different models of how antimicrobial peptides form pores in bacterial membranes and how they kill microorganisms through intracellular mechanisms. The author synthesized evidence from structural, biophysical, and microbiological studies across invertebrate, plant, and animal species.
Who was studied
Review covering antimicrobial peptides from invertebrates, plants, and animals and their mechanisms of action against bacteria
What this study cannot tell us
As a review article, no new experimental data was generated. Many of the pore-forming models were derived from artificial membrane systems that may not perfectly replicate living bacterial membranes. The relative importance of membrane disruption versus intracellular inhibition for any given peptide was not yet fully resolved at the time of publication.
How to read the evidence
This is a comprehensive narrative review in a top-tier journal (Nature Reviews Microbiology) synthesizing decades of mechanistic research. It provides authoritative conceptual framing for the field but does not present new experimental data.
When this study was published
Published in 2005, this is a foundational review that has been cited thousands of times. While newer research has expanded and refined these models, the core framework presented here remains the standard reference for antimicrobial peptide mechanisms.
The bigger picture
This 2005 Nature Reviews paper was a paradigm shift in the antimicrobial peptide field. Before it, most researchers focused almost exclusively on membrane disruption. By highlighting intracellular targets, Brogden opened the door to designing synthetic peptides optimized for specific killing mechanisms — a research direction that has become central to developing peptide antibiotics against drug-resistant bacteria.
Questions still open
- For any given antimicrobial peptide, which mechanism — membrane disruption or intracellular inhibition — is the primary killer?
- Can synthetic peptides be designed to preferentially target specific intracellular bacterial processes?
- Does the multi-mechanism nature of antimicrobial peptides truly prevent resistance development in clinical use?
Common questions
How do antimicrobial peptides kill bacteria?
Why can't bacteria easily develop resistance to antimicrobial peptides?
Read the original research
Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?
Nature reviews. Microbiology, 3(3), 238-50
Citation
Brogden, Kim A. (2005). Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?. Nature reviews. Microbiology, 3(3), 238-50.